PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
A significant proportion of healthcare professionals still tend to favor branded drugs
Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research (AACR) annual meeting on Monday, April 8 and highlighted as part of the official meeting press program
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
Subscribe To Our Newsletter & Stay Updated
